TCL Archive In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List December 2, 1983
TCL Archive Gene Therapy Hyped By Scientists, Panel Tells NIH; Emphasis Must Be Basic Research December 15, 1995